Press Releases

All Releases | Reset Search
Acquisitions | Business/Product | Corporate | Financial

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

Date	Title
12/20/12	Hospira to Host Conference Call for Fourth-Quarter 2012 Results and 2013 Projections
12/10/12	Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
11/07/12	Hospira Reports Third-Quarter 2012 Results
10/18/12	Statement on Drug Shortages and Quality Commitment by Hospira CEO Mike Ball
10/05/12	Hospira to Host Conference Call for Third-quarter 2012 Results
08/30/12	Hospira to Present at the UBS Global Life Sciences Conference Sept. 20, 2012
08/29/12	Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
08/14/12	Hospira to Present at Upcoming Investor Conferences
08/09/12	Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injection
08/01/12	Hospira Reports Second-Quarter 2012 Results
07/31/12	Hospira Expands Board of Directors With Election of Dennis M. Fenton
06/29/12	Hospira to Host Conference Call for Second-quarter 2012 Results
06/29/12	Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
06/11/12	Hospira Introduces Enhanced TheraDoc™ Clinical Surveillance System to Help Hospitals Improve Patient Outcomes and Better Manage Antibiotic Use
05/24/12	I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
05/21/12	Hospira Announces Important Safety Information Regarding Carpuject Syringe System and the Potential For Overfill
05/09/12	Hospira Convenes Its 2012 Annual Meeting of Shareholders
05/08/12	Hospira to Present at Upcoming Investor Conferences
05/01/12	Hospira Reports First-Quarter 2012 Results
04/26/12	Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
04/12/12	Hospira Infusion Pumps Ranked Top Devices in New KLAS Smart Pumps 2012 Report
04/11/12	Hospira Names John B. Elliot Senior Vice President of Operations
04/02/12	Hospira to Host Conference Call for First-quarter 2012 Results
03/09/12	Hospira's TheraDoc(TM) Clinical Surveillance System to Support Infection Prevention and Patient Safety Efforts at CHRISTUS Health
03/08/12	Hospira Receives FDA Clearance for Symbiq(TM) 3.13 Infusion Pump
02/23/12	Hospira Joins the Generic Pharmaceutical Association
02/22/12	Hospira to Present at the Barclays Capital Global Healthcare Conference
02/21/12	Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Month's Supply of New Product Immediately and on Track to Ensure Sustainable Supply
02/14/12	Hospira Working With Urgency to Help Address Methotrexate Shortage
02/14/12	Hospira Reports Fourth-Quarter and Full-Year 2011 Results
02/13/12	Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
02/10/12	Hospira Commends FDA on Draft Biosimilars Guidelines
01/30/12	Hospira Names Richard Davies Chief Commercial Officer
01/19/12	Hospira named a Top 50 Organization for Multicultural Business Opportunities
01/16/12	Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
01/09/12	Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program